Abbott Laboratories
ABT· NYSE
ABTAbbott Laboratories
Filed Aug 7, 2009 · 10-Q · 38 days after period end · 0001104659-09-048013
| Metric | Q2 2009 | Q2 2008 |
|---|---|---|
| Revenue | $7.49B | $7.31B |
| Net Income | $1.29B | $1.32B |
| EPS Diluted | $0.83 | $0.85 |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Abbott Laboratories · CIK 1800 · Engraved from SEC EDGAR
ended Jun 30, 2009 · filed Aug 7, 2009 · 38 d after period end
